| JYSZ2300047 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | License Renew | 2023-10-31 | | Cilag AG;Xian Janssen Pharmaceutical Ltd;Janssen-Cilag AG | | | view |
| JYSZ2300046 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | License Renew | 2023-10-31 | | Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2500075 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2025-03-22 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2500022 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2025-02-07 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2500003 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2025-01-03 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2500002 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2025-01-03 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2400095 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2024-04-25 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2400094 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2024-04-25 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2300204 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2023-12-08 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2300140 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2023-08-18 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2300079 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2023-04-29 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2300078 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2023-04-29 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2300077 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2023-04-29 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2300076 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2023-04-29 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2200057 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2022-03-28 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2200056 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2022-03-28 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2200040 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2022-03-10 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2200015 | 达雷妥尤单抗注射液（皮下注射） | daratumumab | Injection | Biological Products | Supplementary Application | 2022-01-30 | | Cilag AG;Janssen-Cilag International NV | | | view |
| JYSB2200005 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2022-01-07 | | Cilag AG;Janssen-Cilag AG | | | view |
| JYSB2200004 | 达雷妥尤单抗注射液 | daratumumab | Injection | Biological Products | Supplementary Application | 2022-01-07 | | Cilag AG;Janssen-Cilag AG | | | view |
